Boeing’s losses on its Starliner spacecraft topped $2 billion and counting after a rough year.
Continue readingCategory Archives: Uncategorized
Fox reveals plans to launch subscription streaming service this year
Fox has so far been on the sidelines of streaming, with the exception of its free, ad-supported service Tubi.
Continue readingChipotle downplays looming Trump tariffs, says only half of its avocados are from Mexico
In recent years, Chipotle has taken steps to buy more of its avocados outside of Mexico, CEO Scott Boatwright said.
Continue readingRemains of all 67 people killed in D.C. aircraft collision recovered, officials say
The bodies of all 67 people killed in the collision of an American Airlines regional jet with an Army helicopter have been recovered, officials said […]
Continue readingGM cuts 50% of Cruise staff after ending robotaxi business
General Motors is laying off roughly half its employees who remain at its discontinued Cruise robotaxi business.
Continue readingMattel says Barbies and Hot Wheels could soon get more expensive under Trump’s tariffs
Some retailers are looking to pass on the cost of tariffs to their suppliers, but are also considering increasing prices to avoid lower profits.
Continue readingNational Women’s Soccer League agrees to $5 million settlement over past mistreatment of players
The NWSL and three attorneys general have agreed to a settlement over the league’s past mistreatment of players.
Continue readingChipotle earnings beat estimates, but stock falls on weak same-store sales forecast
Chipotle earnings beat estimates as restaurant traffic rises again.
Continue readingDisney tops quarterly profit estimates, but starts to lose Disney+ streaming subscribers
The company’s streaming business reported another quarter of profitability despite a 1% decline in subscribers for Disney+.
Continue readingPharma is hopeful about Trump’s second term — here’s what to expect for drugmakers
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation and patient access to treatments.
Continue reading